Review Article
Cardiovascular Changes in Animal Models of Metabolic Syndrome
Table 2
Main cardiovascular findings in chemically induced animal models of metabolic syndrome.
| Models | Cardiovascular changes |
| MSG-induced SHR | (i) High blood pressure levels | (ii) Reduced heart rate variability | (iii) Decreased spontaneous baroreflex sensibility | (iv) Increased cardiac sympathovagal balance | (v) Increased systolic arterial pressure variability |
| Streptozotocin administration | (i) Systolic and diastolic dysfunction at rest | (ii) Reduced capacity for cardiac adjustment to ā volume overload | (iii) Reduction in baroreflex-mediated ā bradycardia and tachycardia | (iv) Impairment in cardiac vagal tone |
|
|
MSG: monosodium glutamate; SHR: spontaneously hypertensive rat.
|